trending Market Intelligence /marketintelligence/en/news-insights/trending/eonKVuloacFYsVWho72qJg2 content esgSubNav
In This List

XTL Biopharmaceuticals announces stock split

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


XTL Biopharmaceuticals announces stock split

XTL Biopharmaceuticals Ltd. announced a stock split that will take effect Feb. 10.

XTL Biopharmaceuticals' depositary share will represent 100 ordinary shares of the company at that date as opposed to 20 ordinary shares previously.

The split will help the company regain compliance with Nasdaq's listing requirements.